Overview

Safety Study of Sodium Divalproate in Bipolar Disorder in Adolescents

Status:
Completed
Trial end date:
2007-01-01
Target enrollment:
Participant gender:
Summary
- Main objective: To evaluate the clinical and physiological tolerance of sodium divalproate in manic, mixed or hypomanic episodes of bipolar disorder in adolescents treated for 6 months. - Secondary objective: To evaluate the efficacy of sodium divalproate in improving manic, mixed or hypomanic symptoms.
Phase:
Phase 3
Details
Lead Sponsor:
Sanofi